Inventor
GENTLES ROBERT G
US29 patents
⚠️ This page may combine multiple inventors who share the name “GENTLES ROBERT G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
21 patentsUS7153848B2Dec 26, 2006
Inhibitors of HCV replication
BRISTOL MYERS SQUIBB CO90 citations98
US7348425B2Mar 25, 2008
Inhibitors of HCV replication
BRISTOL MYERS SQUIBB CO59 citations94
US7485633B2Feb 3, 2009
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
BRISTOL MYERS SQUIBB CO20 citations92
US7473688B2Jan 6, 2009
Indolobenzazepine HCV NS5B inhibitors
BRISTOL MYERS SQUIBB CO26 citations92
US7456166B2Nov 25, 2008
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
BRISTOL MYERS SQUIBB CO24 citations92
US7452876B2Nov 18, 2008
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
BRISTOL MYERS SQUIBB CO21 citations92
US7547690B2Jun 16, 2009
Compounds for the treatment of Hepatitis C
BRISTOL MYERS SQUIBB CO8 citations84
US7541353B2Jun 2, 2009
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO11 citations84
US7541351B2Jun 2, 2009
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO11 citations84
US7538102B2May 26, 2009
Compounds for the treatment of Hepatitis C
BRISTOL MYERS SQUIBB CO16 citations84
US7521442B2Apr 21, 2009
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
BRISTOL MYERS SQUIBB CO18 citations84
US7521444B2Apr 21, 2009
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO17 citations84
US7521441B2Apr 21, 2009
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
BRISTOL MYERS SQUIBB CO18 citations84
US7521443B2Apr 21, 2009
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
BRISTOL MYERS SQUIBB CO13 citations84
US11866430B2Jan 9, 2024
Naphthyridinone compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO3 citations73
US10669272B2Jun 2, 2020
Substituted naphthyridinone compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO4 citations70
US7652004B2Jan 26, 2010
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO4 citations62
US11713316B2Aug 1, 2023
Substituted naphthyridinone compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO0 citations59
US10954238B1Mar 23, 2021
Substituted naphthyridinone compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO0 citations59
US11964973B2Apr 23, 2024
Substituted bicyclic compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO0 citations50
US8354548B2Jan 15, 2013
Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase
BRISTOL MYERS SQUIBB CO0 citations50